How to choose initial treatment in multiple sclerosis patients: a case-based approach

BACKGROUND: Immunotherapy dramatically changed the natural history of multiple sclerosis (MS), which was classically associated with severe disability. Treatment strategies advocate that early control of disease activity is crucial to avoid progressive disability, and the use of high efficacy drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Apóstolos, Samira Luisa Pereira, Boaventura, Mateus, Mendes, Natalia Trombini, Teixeira, Larissa Silva, Campana, Igor Gusmão
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia - ABNEURO 2022
Materias:
Inflammatory and Demyelinating Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491420/
https://www.ncbi.nlm.nih.gov/pubmed/35976318
http://dx.doi.org/10.1590/0004-282X-ANP-2022-S128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491420/
https://www.ncbi.nlm.nih.gov/pubmed/35976318
http://dx.doi.org/10.1590/0004-282X-ANP-2022-S128

Ejemplares similares